Filter
736
Filtered Results: 736
Text search:
N.
Kumar
Featured
Recommendations
68
New Publications
157
Language
Document type
No document type
406
Studies & Reports
124
Guidelines
123
Manuals
43
Fact sheets
17
Strategic & Response Plan
12
Training Material
7
Situation Updates
2
Resource Platforms
2
Countries / Regions
India
139
Nepal
34
Global
26
Bangladesh
15
Brazil
10
Asia
10
Kenya
9
Western and Central Europe
8
Russia
8
Germany
6
South Africa
6
Malawi
5
Mozambique
5
Myanmar / Burma
5
South–East Asia Region
5
Guinea
4
Cameroon
4
Colombia
4
Lesotho
4
Middle East and North Africa
4
Eastern Europe
4
Burkina Faso
3
Sierra Leone
3
Liberia
3
Ethiopia
3
Ghana
3
Uganda
3
Zambia
3
Tanzania
3
Indonesia
3
Benin
3
Ukraine
3
Ecuador
3
Sri Lanka
3
East and Southern Africa
3
Latin America and the Carribbean
3
Eastern Europe and Central Asia
3
Nigeria
2
Guinea-Bissau
2
Zimbabwe
2
Philippines
2
South Sudan
2
Thailand
2
Rwanda
2
Argentina
2
Angola
2
West and Central Africa
2
Africa
2
Bhutan
2
Tajikistan
2
Senegal
1
Congo, Democratic Republic of
1
Mali
1
Niger
1
Pakistan
1
Jordan
1
Afghanistan
1
Syria
1
Chad
1
China
1
Sudan
1
Eswatini/ Swaziland
1
Burundi
1
Yemen
1
Western Pacific Region
1
Venezuela
1
North Korea
1
Timor Leste/ East Timor
1
Vietnam
1
North America
1
Authors & Publishers
Publication Years
Category
Countries
262
Clinical Guidelines
97
Public Health
55
Women & Child Health
37
Key Resources
17
Capacity Building
5
Pharmacy & Technologies
5
Toolboxes
TB
91
COVID-19
74
HIV
61
Mental Health
44
Disability
33
Caregiver
33
NTDs
31
Planetary Health
28
AMR
15
Pharmacy
12
NCDs
12
Rapid Response
9
Refugee
9
Global Health Education
8
Natural Hazards
7
Health Financing Toolbox
5
Ebola
4
Polio
4
Conflict
2
Cholera
1
Specific Hazards
1
Social Ethics
1
22 December 2020
The COVID-19 vaccine safety guidance manual has been developed upon recommendation and guidance of GACVS members, as well as by experts incorporating current and available information critical to all stakeholders when COVID-19 vaccines will be introduced.
For ease of use, the man...
: interim guidance, 17 February 2021
This document provides interim guidance on the management of the blood supply in response to the pandemic outbreak of coronavirus disease (COVID-19). It emphasizes the importance of being prepared and responding quickly and outlines key actions and measures that...
Scientific Brief, 17 June 2021
This publication is based on the list of clinical interventions selected from clinical guidelines on prevention, screening, diagnosis, treatment, palliative care, monitoring and end of life care. This publication addresses medical devices for six types of cancer: breast, cervical, colorectal, leukem...
Since the start of the pandemic, the region has been hit by multiple natural and biological disasters. At the same time, climate change has continued to warm the world, exacerbating the impacts of many of these disasters. The *Asia-Pacific Disaster Report 2021, *also launched today, shows that the p...
interim guidance, 19 July 2021 (arabic version)
La présente Stratégie pour des infrastructures sanitaires de qualité en Afrique2021-2030 (SISQA) répond à une demande des gouverneurs de la Banque africaine de développement (la BAD ou la Banque) invitant l’institution à définir son rôle dans la lutte contre les déficits d’infrastructu...
Recommendations on the management of diabetes mellitis during the COVID-19 pandemic
Recommendations for in-patient management of COVID-19 in adult patients
Version 10, November 2020.
Following review of evidence and advice from the Technical Advisory Group (TAG) on Tuberculosis (TB) Diagnostics and Laboratory Strengthening, the World Health Organization (WHO) announces that current WHO recommendations for the use of interferon-gamma release assays (IGRA) are also valid for Beij...
Hypertension and COVID-19: Scientific report - 17 June 2021
In 2015, 5.9 million children under age five died (1). The major causes of child deaths globally are pneumonia, prematurity, intrapartum-related complications, neonatal sepsis, congenital anomalies, diarrhoea, injuries and malaria (2). Most of these diseases and conditions are at least partially cau...
En 2015, murieron 5,9 millones de niños menores de cinco años (1). Las principales causas de muerte en los niños a nivel mundial son la neumonía, la prematuridad, las complicaciones durante el parto, la sepsis neonatal, las anomalías congénitas, las enfermedades diarreicas, las lesiones ...
En 2015, 5,9 millions d'enfants de moins de cinq ans sont décédés (1). Les principales causes de mortalité infantile dans le monde sont la pneumonie, la prématurité, les complications durant l'accouchement, la septicémie néonatale, les anomalies congénitales, la diarrhée, les tra...
Reliable cause specic mortality statistics are the cornerstone of national health information
systems. They are essential for evidence-based decision making for monitoring health of
populations, health services planning and delivery, programme implementation, policy development
and epidemiolog...
The socioeconomic factors and public health inadequacies that facilitated the rapid spread of this infection continue to exist. As it is a new and emerging disease it has not received sufficient coverage yet in the medical curricula of Member States. Specific treatment is not available, and there is...
This chapter discusses the antibacterial treatment of leprosy infections. Antibiotic treatment is
a key component of leprosy treatment, as it is vital to prevent the progression of the infection.
Treatment with rifampin and other antibiotics is highly effective and cures 98% of patients with
the ...
